tiba.bio/a-shot-in-the-…

tiba.bio/nih-funding-op…

#Exclusive: A Foot and Mouth Disease mRNA vaccine deal has been signed between the NSW government and US company Tiba Biotech | #nswpol

Great news re #mRNA animal vaccine development here in NSW in collaboration between Depart. Primary Industries & Tiba Biotech Tiba Biotech LLC in the US! Stay tuned to hear more!

#BREAKINGNEWS: Today #TibaBiotech announced a 5yr, US$MM agreement w/ the Australian state government of New South Wales (#NSW) to develop #mRNA #vaccines against emergency animal diseases that threaten AU’s #livestock industry & domestic #foodsecurity. (tiba.bio/tiba-nsw/)

Partnership to address emerging animal disease threats in Australia nationalhogfarmer.com/news/partnersh…

#TibaBiotech and the Australian State of New South Wales Enter Partnership to Address Emergency Animal Disease Threats via MassBio (massbio.org/news/member-ne…) #biotech #innovation #preclinical #vaccines #mRNA

#TibaBiotech co-founder & CFO, Peter McGrath, has returned to Australia to work closely w/ #NSW to manage the private/public initiative to address #animaldisease threats in the region 10 News First Sydney (tiba.bio/tiba-biotechs-…) #biotech #vaccines #mRNA #innovation #diseasecontrol

CEPI announces new partnership with @TibaBiotech to evaluate next-generation #RNA vaccine platform tech to respond to Disease X - the 1st award in our innovation programme to improve rapid-response RNA vaccine tech against future outbreaks 👇 bit.ly/3kfOwuU

Our CEO, Richard Hatchett said: "We're excited by Tiba Biotech LLC's nanoparticle approach, which we think may reduce adverse reactions and improve the thermostability of mRNA vaccines.” This could make RNA vaccines easier to use and more accessible in many countries

The $2m seed funding will be used to develop an RNA vaccine for Japanese Encephalitis Virus with the aim of generating crucial data about the potential for @TibaBiotech’s platform to make RNA vaccines which are less costly, more effective, and have fewer side effects

#BREAKINGNEWS CEPI partners w/ #TibaBiotech to evaluate #nextgen #RNA #vaccine platform #technology. 1st award granted under CEPI’s #innovation program will provide US$2M to advance Tiba Biotech’s novel RNA nanoparticle delivery platform. tiba.bio/cepi-tiba-biot…

💉Major boost for vaccines targeting ‘Disease X’. Cepi has invested in a project to develop cheaper, more effective shots with fewer side effects. Sarah Newey reports for The Telegraph 🔽 telegraph.co.uk/global-health/…

ICYMI: CEPI and Tiba Biotech LLC are partnering to evaluate Tiba's next-gen RNA vaccine platform tech which could offer substantial advantages over existing RNA vaccines 👇

Congratulations to one of the MIT Startup Exchange (STEX) members, Tiba Biotech LLC, for recently becoming a partner with CEPI. The new partnership will focus on evaluating Tiba Biotech's next-generation RNA vaccine platform technology. (tiba.bio/cepi-tiba-biot…)

Precision Vaccinations reports on CEPI and Tiba Biotech’s #partnership to evaluate next-generation #RNA vaccine platform technology. (precisionvaccinations.com/next-gen-rna-v… ) #biotech #innovation #mrna #vaccines #technology #partnership

Our partnership with CEPI is the focus of this article in Science & Enterprise. (sciencebusiness.technewslit.com/?p=44324) #vaccines #mRNA #innovation #biotech #preclinical #biopharma #technology #JEV #TibaBiotech

Pour nos ami(e)s francophones, voici un reportage sur le parteneriat entre CEPI et Tiba Biotech. #innovation #ARNm #vaccins #biotech (dernieres-nouvelles.com/coup-de-pouce-… )

Scrip’s Tech Transfer Roundup reports on Tiba Biotech and CEPI planning ahead for the next pandemic. #innovation #mrna #biotech #vaccines #pandemic (tiba.bio/wp-content/upl…)

#BREAKINGNEWS: BARDA partners with #TibaBiotech to develop groundbreaking #therapeutics against #influenza. Learn more tiba.bio/barda-partners…